A-FABP (125 and 250 mg/kg, 1 and 12 h after MCAO, and then once per day for the next six consecutive days) aggravates I/R injury in stroke by activating the JNK pathway, promoting MMP-9 expression, which causes BBB disruption [18]. The gene discussed is MAPK8; the disease is stroke disorder.